Posted on 12/21/20
Did U.K. and Canadian Authorizations of Pfizer's COVID Vaccine Pressure the U.S.?
On Dec. 12, 2020, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to BNT162b2, the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) . . .
Posted on 12/21/20
Joe Biden to Receive First Dose of Pfizer/BioNTech Vaccine on Monday
The most high-profile American in 2021 is going to receive his initial dose of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine as 2020 fades away. President-Elect . . .
Posted on 12/21/20
Better Coronavirus Stock: Pfizer vs. BioNTech
Mercedes or Porsche? Steak or sushi? Two things can both be good but very different. For investors, the best coronavirus stock may depend on who's choosing. . . .
Posted on 12/21/20
Here's Why Pfizer's Vaccine Is So Important
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) became the first drugmakers to win U.S. emergency use authorization for their COVID-19 vaccine BNT162b2 over the weekend. On Monday, the first Americans . . .
Posted on 12/21/20
4 Reasons You Should Buy Pfizer Stock Right Now
The ongoing rollout of the first authorized coronavirus vaccine has heaps of everyday investors wondering if Pfizer (NYSE:PFE), the company credited with making it happen so . . .
Posted on 12/18/20
Scopus BioPharma Closes of IPO
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of its initial public offering. The underwriters for the initial public offering exercised their over-allotment option in . . .
Posted on 12/18/20
Why Didn't Pfizer Stock Jump More After Winning Authorization for Its COVID Vaccine?
Pfizer(NYSE:PFE) received great news last Thursday that an advisory committee to the U.S. Food and Drug Administration (FDA) overwhelmingly recommended Emergency Use Authorization (EUA) for its . . .
Posted on 12/18/20
Will Moderna Stock Soar If Its COVID Vaccine Is Authorized?
Pfizer's (NYSE:PFE) share price actually fell a little after an advisory committee to the U.S. Food and Drug Administration (FDA) recommended Emergency Use Authorization (EUA) for . . .
Posted on 12/17/20
SCYNEXIS Prices of $85 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of common stock, pre-funded warrants . . .
Posted on 12/17/20
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
It might seem like everything is going well for COVID-19 vaccines right now. The first Americans have already been vaccinated with Pfizer's (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) . . .
Posted on 12/17/20
What Pfizer's Vaccine Authorization Means for Moderna
The U.S. Food and Drug Administration (FDA) granted Pfizer's (NYSE:PFE) coronavirus vaccine candidate Emergency Use Authorization (EUA) last week. On Dec. 17, the FDA will meet . . .
Posted on 12/17/20
3 Things Pfizer's Coronavirus Vaccine Still Has to Prove
The U.S. Food and Drug Administration met with its vaccines advisory panel of experts on Dec. 10 to discuss Pfizer's (NYSE:PFE) coronavirus vaccine candidate. The FDA . . .
Posted on 12/17/20
Is Teladoc Stock a Buy?
Telehealth has been growing in popularity this year, as patients are in need of much more flexible healthcare options amid the coronavirus pandemic. With hospitals deferring . . .
Posted on 12/17/20
Is This Recent IPO Stock The Teladoc of Medicare?
The world has clearly shifted to online aggregation platforms that simplify peoples' lives and make complicated choices more efficient. Whether it be used cars -- think . . .
Posted on 12/17/20
SCYNEXIS Announces Launch of $50 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that it has commenced an underwritten public offering of shares of its . . .
Posted on 12/16/20
TG Therapeutics Prices Upsized Public Offering of Common Stock
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company developing medicines for patients with B-cell mediated diseases, today announced . . .
Posted on 12/16/20
Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently won U.S. emergency use authorization (EUA) for their COVID-19 vaccine. An EUA for Moderna's (NASDAQ:MRNA) vaccine could be only days away. In . . .
Posted on 12/16/20
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
With all the recent focus on COVID-19 vaccines and the successes of a new gene-based approach to developing drugs, it's understandable that investors might lose sight . . .
Posted on 12/16/20
Arvinas Prices $400M Public Offering of Common Stock
NEW HAVEN, Conn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 12/15/20
EmendoBio Acquired by AnGes
EmendoBio Inc., a leader in next-generation novel nuclease discovery and gene editing technologies, today announced that AnGes, Inc.,
Posted on 12/15/20
Welltower and Wafra Announce $550 Million Medical Office Building Joint Venture
Wafra Inc., a global alternative investment platform, and Welltower Inc. (NYSE: WELL), an S&P 500 healthcare real estate investment trust (REIT), today announced a $550 million . . .
Posted on 12/15/20
Eli Lilly to Acquire Prevail Therapeutics
Eli Lilly and Company (NYSE: LLY) and Prevail Therapeutics Inc. (NASDAQ: PRVL) today announced a definitive agreement for Lilly to acquire Prevail for $22.50 per share . . .
Posted on 12/15/20
When Will Pfizer and Moderna Recognize COVID Vaccine Revenue?
Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) are waiting on pins and needles to receive emergency use authorizations (EUA) for their COVID-19 vaccines. And investors are anxiously awaiting the big . . .
Posted on 12/15/20
Here's Why Merck Made a Mistake by Selling Its Moderna Stake
Merck(NYSE:MRK) was one of the earliest investors in Moderna(NASDAQ:MRNA), buying a position in the biotech even before it went public in late 2018. Earlier this month, . . .
Posted on 12/15/20
Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?
Reports emerged recently that the Trump administration turned down an opportunity to secure more doses of Pfizer(NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine, BNT162b2. In this Motley . . .
New York
